These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8521768)

  • 1. Approaches to meeting the criteria for fixed dose antihypertensive combinations. Focus on metoprolol.
    Kendall MJ
    Drugs; 1995 Sep; 50(3):454-64. PubMed ID: 8521768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the therapeutic balance between efficacy and tolerability in antihypertensive drugs--the rationale and benefits of combining felodipine and metoprolol.
    Trenkwalder P; Elmfeldt D
    J Hum Hypertens; 1995 Jul; 9 Suppl 2():S37-42. PubMed ID: 7562898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
    Dahlöf B; Hosie J
    Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL; Clissold SP
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a felodipine-metoprolol combination tablet vs each component alone as antihypertensive therapy. The German Multicentre Study Group.
    Hoffmann J
    Blood Press Suppl; 1993; 1():30-6. PubMed ID: 8173688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term antihypertensive efficacy and safety of a new felodipine-metoprolol combination tablet. The Swedish/UK and German Study Groups.
    Hosie J; Dahlöf B; Klein G
    Blood Press Suppl; 1993; 1():46-50. PubMed ID: 8173690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone.
    Dahlöf B; Jönsson L; Borgholst O; Ekblad G; Engstrand C; Grundestam I; Lindh A
    Blood Press Suppl; 1993; 1():37-45. PubMed ID: 8173689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metoprolol succinate extended release/hydrochlorothiazide combination tablets.
    Hainer JW; Sugg J
    Vasc Health Risk Manag; 2007; 3(3):279-88. PubMed ID: 17703635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Felodipine/metoprolol: a review of the fixed dose controlled release formulation in the management of essential hypertension.
    Haria M; Plosker GL; Markham A
    Drugs; 2000 Jan; 59(1):141-57. PubMed ID: 10718104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy, safety and tolerance of Felodipine controlled release tablets and Felodipine controlled release tablets associated combination therapy in the treatment of mild to moderate essential hypertension in China].
    Chen YY; Sun NL; Zhang WZ; Wu HY; Zhang L; Yu ZQ; Zhang FC; Xiang XP; Liu HL; Shen FR; Tao J; Zhao JA
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 39(6):619-23. PubMed ID: 18087554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal felodipine dose when combined with metoprolol in arterial hypertension: a Swedish multicenter study within primary health care. Swedish General Practitioner Felodipine Study Group.
    Brun J; Fröberg L; Kronmann P; Olsson LB; Skoog P; Tygesen G; Bengtsson C; Scherstén B; Tibblin G
    J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S60-4. PubMed ID: 1693732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction.
    Dahlöf B; Degl' Innocenti A; Elmfeldt D; Puig JG; Gundersen T; Hosie J; Januszewicz W; Lindström CJ; Magometschnigg D; Tanser P; Toutouzas P; Waeber B; Wiklund I
    Am J Hypertens; 2005 Oct; 18(10):1313-9. PubMed ID: 16202854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ramipril/felodipine extended-release fixed-dose combination: a review of its use in the management of essential hypertension.
    Cvetković RS; Plosker GL
    Drugs; 2005; 65(13):1851-68. PubMed ID: 16114982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bisoprolol to a metoprolol CR/ZOK tablet for control of heart rate and blood pressure in mild-to-moderate hypertensive patients: the CREATIVE study.
    Yang T; Jiang Y; Hao Y; Zhou S; Xu X; Qu B; Lin X; Ma T
    Hypertens Res; 2017 Jan; 40(1):79-86. PubMed ID: 27534738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability and well-being with metoprolol in a controlled release (CR/ZOK) formulation: a review article.
    Dimenäs E; Dahlöf C
    J Clin Pharmacol; 1990 Feb; 30(S2):S92-7. PubMed ID: 2179287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.
    Scholze J; Grimm E; Herrmann D; Unger T; Kintscher U
    Circulation; 2007 Apr; 115(15):1991-8. PubMed ID: 17404163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using fixed-dose combination therapies to achieve blood pressure goals.
    Chrysant SG
    Clin Drug Investig; 2008; 28(11):713-34. PubMed ID: 18840014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of hydrochlorothiazide and a fixed combination of metoprolol and hydrochlorothiazide essential hypertension.
    Dafgärd T; Forsén B; Lindahl T
    Ann Clin Res; 1981; 13 Suppl 30():37-44. PubMed ID: 7027892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.